AIA Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIA Group's BIIB Position: Q2 2026 in Review
AIA Group reduced its Biogen (BIIB) stake by 41% in Q2 2026, selling an estimated $724K and leaving 5,545 shares worth $1.2M. The position accounts for 0.02% of the portfolio, ranked #239.
AIA Group first reported a position in BIIB in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.1M in Q3 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- AIA Group held 5,545 shares of Biogen worth $1.2M as of Q2 2026.
- AIA Group sold 3,784 Biogen shares in Q2 2026, an estimated $724K.
- Biogen made up 0.02% of AIA Group's portfolio in Q2 2026, its #239 holding.
- AIA Group first reported a position in Biogen in Q4 2020 and has held it in 21 quarters since.
- AIA Group's Biogen position peaked at $3.1M in Q3 2025.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.